Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Premium
Indulgence
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Glenmark Pharma shines as September quarter marks rebound in earnings
Analysts are upgrading their ratings as they expect sales momentum in the US and domestic markets to improve
Glenmark Q2 net down 4.23% at Rs 214 crore
The overall performance was driven by our India, Europe and API business: Glenmark Pharmaceuticals
